Skip to main content
Fig. 1 | Egyptian Journal of Medical Human Genetics

Fig. 1

From: A case–control study of BRCA1 founder mutations 185delAG and 5382insC in a cohort of Egyptian ovarian cancer patients using pyrosequencing technique

Fig. 1

Agarose gel electrophoresis for BRCA1 185delAG & BRCA1 5382insC founder mutations. a Agarose gel electrophoresis (2%) for BRCA1 5382insC in which the product band is at 72 bp. The first lane: size marker (1 Kb ladder), The second lane: negative control; the band is a primer dimer band. Lanes 3, 4, 5 and 6: four FOC patients. b Agarose gel electrophoresis (2%) for BRCA1 185delAG in which the product band is at 80 bp in FOC patients

Back to article page